Itau Unibanco Holding S.A. Makes New Investment in The Clorox Company (NYSE:CLX)

Itau Unibanco Holding S.A. bought a new position in shares of The Clorox Company (NYSE:CLXFree Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 11,825 shares of the company’s stock, valued at approximately $1,920,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in Clorox by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company’s stock worth $2,518,517,000 after buying an additional 124,428 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Clorox by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company’s stock worth $501,925,000 after acquiring an additional 69,969 shares in the last quarter. Stifel Financial Corp boosted its stake in shares of Clorox by 0.4% during the 4th quarter. Stifel Financial Corp now owns 2,344,408 shares of the company’s stock worth $380,761,000 after acquiring an additional 9,582 shares in the last quarter. Norges Bank acquired a new stake in shares of Clorox in the 4th quarter worth approximately $259,041,000. Finally, Northern Trust Corp increased its stake in Clorox by 18.2% in the 4th quarter. Northern Trust Corp now owns 1,494,265 shares of the company’s stock valued at $242,684,000 after purchasing an additional 230,173 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. JPMorgan Chase & Co. lowered their price target on shares of Clorox from $173.00 to $151.00 and set a “neutral” rating on the stock in a research report on Friday, April 11th. DA Davidson reduced their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Evercore ISI raised their price target on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, Citigroup reduced their price objective on Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research report on Monday, April 14th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $153.83.

Check Out Our Latest Stock Analysis on CLX

Clorox Stock Up 0.7 %

Shares of NYSE CLX opened at $142.15 on Thursday. The stock has a market capitalization of $17.51 billion, a PE ratio of 38.84, a P/E/G ratio of 2.62 and a beta of 0.61. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The firm has a fifty day moving average of $144.83 and a 200-day moving average of $155.29. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the firm earned $2.16 earnings per share. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.43%. Clorox’s payout ratio is 133.33%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.